Baak JP - Search Results

1

The additional prognostic value of morphometric nuclear arrangement and DNA-ploidy to other morphometric and stereologic features in endometrial hyperplasias.

Baak JP, Kuik DJ, Bezemer PD. Baak JP, et al. Int J Gynecol Cancer. 1994 Sep;4(5):289-297. doi: 10.1046/j.1525-1438.1994.04050289.x. Int J Gynecol Cancer. 1994. PMID: 11578420

2

The significance of differences in prognostic value of quantitative pathologic features in FIGO stage III and IV serous adenocarcinoma of the ovary between a group of Danish patients and other groups.

Brinkhuis M, Mogensen O, Bichel P, Baak JP. Brinkhuis M, et al. Among authors: baak jp. Int J Gynecol Cancer. 1995 Sep;5(5):355-360. doi: 10.1046/j.1525-1438.1995.05050355.x. Int J Gynecol Cancer. 1995. PMID: 11578504

3

Further evaluation of reproducibility and prognostic value of histologic typing and grading in FIGO stage I ovarian cancer patients without systemic locoregional adjuvant treatment.

Brugghe J, Baak JP, Wiltshaw E, Fisher C. Brugghe J, et al. Among authors: baak jp. Int J Gynecol Cancer. 1995 Jul;5(4):262-268. doi: 10.1046/j.1525-1438.1995.05040262.x. Int J Gynecol Cancer. 1995. PMID: 11578487

4

Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-up.

Baak JP, Snijders WP, Van Diest PJ, Armee-Horváth E, Kenemans P. Baak JP, et al. Int J Gynecol Cancer. 1995 Mar;5(2):112-116. doi: 10.1046/j.1525-1438.1995.05020112.x. Int J Gynecol Cancer. 1995. PMID: 11578464

5

Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab')2: pharmacokinetics, tissue distribution, and tumor imaging.

Buist MR, Kenemans P, Vermorken JB, Golding RP, Burger CW, Den Hollander W, Van Kamp GJ, Van Lingen A, Teule GJ, Baak JP, Roos JC. Buist MR, et al. Among authors: baak jp. Int J Gynecol Cancer. 1992 Jan;2(1):23-34. doi: 10.1046/j.1525-1438.1992.02010023.x. Int J Gynecol Cancer. 1992. PMID: 11576231

6

Quantitative pathologic features as predictors of long-term survival in patients with advanced ovarian cancer treated with cisplatin.

Van Diest PJ, Baak JP, Brugghe J, Van De Burg ME, Van Oosterom AT, Neijt JP. Van Diest PJ, et al. Among authors: baak jp. Int J Gynecol Cancer. 1994 May;4(3):174-179. doi: 10.1046/j.1525-1438.1994.04030174.x. Int J Gynecol Cancer. 1994. PMID: 11578403

7

Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma.

van der Putten HW, Baak JP, Koenders TJ, Kurver PH, Stolk HG, Stolte LA. van der Putten HW, et al. Among authors: baak jp. Cancer. 1989 Apr 1;63(7):1378-87. doi: 10.1002/1097-0142(19890401)63:7<1378::aid-cncr2820630724>3.0.co;2-q. Cancer. 1989. PMID: 2920365

8

DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.

Williams RA, Baak JP, Meijer GA, Charlton IG. Williams RA, et al. Among authors: baak jp. Anal Quant Cytol Histol. 1999 Oct;21(5):437-44. Anal Quant Cytol Histol. 1999. PMID: 10560527

9

Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma.

Tosi P, Luzi P, Baak JP, Miracco C, Santopietro R, Vindigni C, Mattei FM, Acconcia A, Massai MR. Tosi P, et al. Among authors: baak jp. Cancer. 1986 Dec 1;58(11):2512-8. doi: 10.1002/1097-0142(19861201)58:11<2512::aid-cncr2820581126>3.0.co;2-o. Cancer. 1986. PMID: 3768843

10

Adenocarcinoma in situ of the cervix: an underdiagnosed lesion.

Boon ME, Baak JP, Kurver PJ, Overdiep SH, Verdonk GW. Boon ME, et al. Among authors: baak jp. Cancer. 1981 Aug 1;48(3):768-73. doi: 10.1002/1097-0142(19810801)48:3<768::aid-cncr2820480318>3.0.co;2-l. Cancer. 1981. PMID: 7248903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results